Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-165-9 | CAS number: 7440-57-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11 December 1998 to 08 January 1999
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant, guideline study, available as unpublished report, accepted without restriction
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 999
- Report date:
- 1999
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Principles of method if other than guideline:
- Also according to:
* "Biological evaluation of medical devices"
* ISO 10993-1: 1997, "Evaluation and testing"
* ISO 10993-10: 1995, (6.3) "Tests for irritation and sensitization"
* ISO 10993-12: 1996, "Sample preparation and reference material"
* DIN EN 30993-1: 1994 and DIN EN ISO 7405:1998 (5.2.2e) "Preclinical evaluation of biocompatibility of medical devices used in dentistry - Test methods" - GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- Gold
- EC Number:
- 231-165-9
- EC Name:
- Gold
- Cas Number:
- 7440-57-5
- Molecular formula:
- Au
- IUPAC Name:
- gold(1+)
- Details on test material:
- Name of test material (as cited in study report): Ectectior Vision, dental alloy for the ceramic fused-to-metal technic
- Physical state: solid
- Composition of test material, percentage of components: Au 98.2%, Ti 1.7%, Ir 0.1%
- Lot/batch No.: 2974
- Expiration date of the lot/batch: none
- Stability under test conditions: Unlimited stable
- Storage condition of test material: at room temperature
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelman GmbH, D-33178 Borchen
- Age at study initiation: Not reported
- Weight at study initiation: 301 - 316 g
- Housing: Terluran cages on Altromin saw fiber bedding. Max caging group size: 10 animals.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): not reported
- Acclimation period: Under test conditions for one week.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3°C
- Humidity (%): 55 ± 10%
- Air changes (per hr): at least 10x / hour
- Photoperiod (hrs dark / hrs light): Artificial lighting, 12 hours light, 12 hours dark
IN-LIFE DATES: Not reported
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- physiological saline
- Concentration / amount:
- Three pairs of 0.1 ml injections were administered, with 0, 100 and 50% concentration of test item in Freund's adjuvant complete. Topic application was a solid specimen of test item, dimensions 15 x 30 x 1 mm.
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- physiological saline
- Concentration / amount:
- Three pairs of 0.1 ml injections were administered, with 0, 100 and 50% concentration of test item in Freund's adjuvant complete. Topic application was a solid specimen of test item, dimensions 15 x 30 x 1 mm.
- No. of animals per dose:
- 10
- Details on study design:
- RANGE FINDING TESTS: Not reported
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 1 interdermal, 1 topical
- Exposure period: Interdermal injections: Day 0, Topical: 48 hour patch (days 7 & 8)
- Test groups: 1
- Control group: 1
- Site: Shoulder region
- Frequency of applications: No repetition
- Duration: Topical: 48 hour patch
- Concentrations: Three pairs of 0.1 ml injections were administered, with 0, 100 and 50% concentration of test item in Freund's adjuvant complete. Topic application was a solid specimen of test item, dimensions 15 x 30 x 1 mm.
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 20
- Exposure period: 24 hours
- Test groups: 1
- Control group: 1
- Site: Left flank
- Concentrations: Solid specimen of test item, dimensions 15 x 30 x 1 mm.
- Evaluation (hr after challenge): 24, 48 & 72 hours - Challenge controls:
- 5 animals were inducted with injections lacking the test item.
- Positive control substance(s):
- yes
- Remarks:
- Mercaptobenzothiazole
Results and discussion
- Positive control results:
- see table 1
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Reading:
- other: 3rd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: other: 3rd reading. . Hours after challenge: 72.0. Group: test group. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: none.
- Reading:
- other: 3rd reading
- Hours after challenge:
- 72
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- other: Reading: other: 3rd reading. . Hours after challenge: 72.0. Group: negative control. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: none.
Any other information on results incl. tables
Table 1 - Frequency of Sensitization in Positive Control Animals
Erythema Grade | Oedema Grade | ||||||||||
Time after challenge treatment (hours) | E0 | E1 | E2 | E3 | E4 | O0 | O1 | O2 | O3 | O4 | % |
24 | 4 | 4 | 2 | 10 | 60 | ||||||
48 | 4 | 3 | 3 | 10 | 60 | ||||||
72 | 8 | 2 | 10 | 20 |
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- A Guinea-Pig Maximisation test showed that gold is not a skin sensitizer.
- Executive summary:
A GLP-compliant, OECD Guideline (406) Guinea-Pig Maximisation test showed that gold is not a skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.